Consonance Capital

Consonance Capital Management as of June 30, 2015

Portfolio Holdings for Consonance Capital Management

Consonance Capital Management holds 28 positions in its portfolio as reported in the June 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Retrophin 11.3 $113M 3.4M 33.15
Insys Therapeutics 10.8 $107M 3.0M 35.92
Eagle Pharmaceuticals (EGRX) 9.6 $96M 1.2M 80.86
Abbvie (ABBV) 8.8 $87M 1.3M 67.19
Akorn 8.1 $81M 1.8M 43.66
United Therapeutics Corporation (UTHR) 6.8 $67M 387k 173.95
Cardiovascular Systems 6.6 $66M 2.5M 26.45
Biosante Pharmaceuticals (ANIP) 6.6 $66M 1.1M 62.05
Orthofix International Nv Com Stk 5.7 $57M 1.7M 33.12
Enanta Pharmaceuticals (ENTA) 5.6 $56M 1.2M 44.99
Pacific Biosciences of California (PACB) 3.1 $31M 5.4M 5.76
Clovis Oncology 2.7 $27M 303k 87.88
Osiris Therapeutics 2.3 $23M 1.2M 19.46
Catalyst Pharmaceutical Partners (CPRX) 2.3 $23M 5.5M 4.13
Celldex Therapeutics 1.9 $19M 752k 25.22
Epirus Biopharmaceuticals In (EPRSQ) 1.3 $13M 2.3M 5.71
Derma Sciences 1.3 $13M 1.8M 7.16
Healthways 1.2 $12M 1.0M 11.98
Adma Biologics (ADMA) 1.0 $9.6M 1.0M 9.26
Veracyte (VCYT) 0.8 $8.4M 2.4M 3.57
Nanostring Technologies (NSTG) 0.7 $6.9M 449k 15.42
Merus Labs Intl 0.4 $3.8M 1.6M 2.33
Vericel (VCEL) 0.3 $3.3M 299k 11.14
Sientra 0.3 $3.3M 132k 25.23
BioTime 0.2 $2.4M 656k 3.63
Imprivata 0.2 $1.6M 96k 16.36
Biolase Technology 0.1 $1.2M 668k 1.74
eHealth (EHTH) 0.0 $67k 5.2k 12.78